ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

ASCO Expanding Tools To Improve Coordination Of Cancer Treatment

November 30, 2007

Wilmot Researchers Study Combination for Lymphoma

September 26, 2003

Evansvile CCOP Withdrawn, Cites Budget Cut, DR

September 9, 1983

Community Assn. Meeting Includes Provocative Workshops

January 31, 1975

James Shannon, 89, Led NIH In 1960’s Period of Growth

May 27, 1994

Gene Delivery System Targets Tumor Blood Vessels In Dogs

March 27, 2009